BAG3 deficiency results in fulminant myopathy and early lethality
about
Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathyA genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathyThe nucleotide exchange factors of Hsp70 molecular chaperonesKeep your heart in shape: molecular chaperone networks for treating heart diseaseA Role for the Chaperone Complex BAG3-HSPB8 in Actin Dynamics, Spindle Orientation and Proper Chromosome Segregation during MitosisDisrupted autophagy undermines skeletal muscle adaptation and integrityBAG3: a new player in the heart failure paradigmBAG3 and Hsc70 interact with actin capping protein CapZ to maintain myofibrillar integrity under mechanical stressMyofibrillar myopathiesCardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 SignalingA BAG3 Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy.Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathyThe anti-apoptotic activity of BAG3 is restricted by caspases and the proteasome.Strain-dependent variation in collateral circulatory function in mouse hindlimb.Hereditary Dilated Cardiomyopathy: Recent Advances in Genetic Diagnostics.IKK{gamma} protein is a target of BAG3 regulatory activity in human tumor growth.BAG3 directly interacts with mutated alphaB-crystallin to suppress its aggregation and toxicity.The BAG3 gene variants in Polish patients with dilated cardiomyopathy: four novel mutations and a genotype-phenotype correlation.Inheritance patterns and phenotypic features of myofibrillar myopathy associated with a BAG3 mutationGetting folded: chaperone proteins in muscle development, maintenance and disease.Identification of the Drosophila ortholog of HSPB8: implication of HSPB8 loss of function in protein folding diseases.The stress protein BAG3 stabilizes Mcl-1 protein and promotes survival of cancer cells and resistance to antagonist ABT-737BAG3 expression in glioblastoma cells promotes accumulation of ubiquitinated clients in an Hsp70-dependent manner.Mutation in BAG3 causes severe dominant childhood muscular dystrophy.Decreased levels of BAG3 in a family with a rare variant and in idiopathic dilated cardiomyopathyThe sarcomeric Z-disc and Z-discopathies.Cordyceps sinensis attenuates renal fibrosis and suppresses BAG3 induction in obstructed rat kidneyInduction and adaptation of chaperone-assisted selective autophagy CASA in response to resistance exercise in human skeletal muscle.Familial Dilated Cardiomyopathy Caused by a Novel Frameshift in the BAG3 Gene.A novel miR-371a-5p-mediated pathway, leading to BAG3 upregulation in cardiomyocytes in response to epinephrine, is lost in Takotsubo cardiomyopathyExpression of Bis in the mouse gastrointestinal system.Chaperones in autophagy.BAG3 regulates ECM accumulation in renal proximal tubular cells induced by TGF-β1.BAG3-related myopathy, polyneuropathy and cardiomyopathy with long QT syndromeBAG3 regulates contractility and Ca(2+) homeostasis in adult mouse ventricular myocytesCardiac Dysfunction in HIV-1 Transgenic Mouse: Role of Stress and BAG3Myosin heavy chain is stabilized by BCL-2 interacting cell death suppressor (BIS) in skeletal muscleThe Hippo signal transduction network for exercise physiologistsImplication of Bcl-2-associated athanogene 3 in fibroblast growth factor-2-mediated epithelial-mesenchymal transition in renal epithelial cells.Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.
P2860
Q24594051-5EFE17FB-8651-4A13-AC9D-CDF83419D2E7Q24601469-B94DDC9D-4AF4-4D92-9395-5838C464B41AQ26766367-FEFBD9E0-06C2-4F5B-9B15-5E4FFC5ECF22Q27010429-5729FA30-EF0E-42E1-8477-605846FDDFDAQ27310178-064681AB-090C-4238-8409-32E71518ABEAQ28077297-B2491D24-ED9E-4038-97BC-60B63AB6DDF9Q28088321-0C986DAD-B52F-44D4-ABBB-2ED6E49A7799Q28294601-732C34FE-DF0C-4D38-A620-A23E43506228Q28303812-EC9C735C-7873-4EDB-B5CC-041D67F73BCDQ28385823-E4F86BA9-3478-479A-8734-68F0642CF1C9Q30252524-75F078A2-4423-4819-8FA5-3902159BC15FQ30364996-A0C36BF6-7795-411C-BECC-6A743BD878D2Q33427843-140027F0-BA64-481C-A755-8BFAE02A5D66Q33605564-CB64F3EA-351A-4392-BFD7-A4129B39EAB6Q33740770-7594DC6D-DBD1-4B1A-ACA0-70601066BB05Q33842059-D079E758-D9F7-4583-9020-1809E8EA615FQ33851451-75352E18-DE1A-40F0-AC9E-94A5C1EF88B6Q33927632-F470848A-D8A7-4FD3-86E4-39DFD8B043DBQ33976346-F9AA8899-3B68-40AE-B209-089E0FFE8269Q34055646-160C74F9-7DBC-4576-8433-DFA581976AE0Q34333825-3BFEECE5-B7FF-4DC6-84C6-743343197191Q34557856-5F7AA3FA-CC28-44D6-A0D3-DEDD58E35D3CQ34685246-0C20073E-B1B1-4571-97EE-0DA579594404Q34904884-3AAE9A3B-566F-465E-B7FC-4704620DCF03Q34974147-5A9D76F1-9217-470E-B9EE-666B16219D74Q35418525-CE191C58-F39C-4759-9B8D-9CCFD81823E2Q35826492-39B5614E-47EB-4615-83DF-32CA3200AE16Q35852833-AF0989AF-B54A-4594-A215-785874A967ABQ36071394-4CE0598D-DF06-4D89-AA94-447A47F0FD47Q36246459-1A4B40BC-22A7-489E-B2BB-CBA7A7C52D0FQ36319932-FCFA5E14-EBF1-4A33-9E5A-3E972439FC59Q36413186-6710AA62-3C26-4852-9A17-E242C3E84411Q36516733-E641F410-7521-4668-B9A7-12C89FEBAD5EQ36605196-BDF0BA37-FE45-407A-B143-C16D9F5790CEQ36679768-1A395B92-C2D7-473C-A4BD-BDA96E7735F8Q36827162-8FB0125E-C503-4AC8-9F80-0A790F4FB092Q36865114-AC952085-5842-44B9-A280-85D7122AC74BQ36902243-4E718250-3F21-499A-9F2A-2D47DC657237Q37071172-E3A99402-FE65-4415-8122-B4BAC73B17A1Q37231073-5D69F497-6A97-4422-9E30-ABC38132E6E6
P2860
BAG3 deficiency results in fulminant myopathy and early lethality
description
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im September 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/09/01)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/09/01)
@nl
наукова стаття, опублікована у вересні 2006
@uk
مقالة علمية (نشرت في سبتمبر 2006)
@ar
name
BAG3 deficiency results in fulminant myopathy and early lethality
@ast
BAG3 deficiency results in fulminant myopathy and early lethality
@en
BAG3 deficiency results in fulminant myopathy and early lethality
@nl
type
label
BAG3 deficiency results in fulminant myopathy and early lethality
@ast
BAG3 deficiency results in fulminant myopathy and early lethality
@en
BAG3 deficiency results in fulminant myopathy and early lethality
@nl
prefLabel
BAG3 deficiency results in fulminant myopathy and early lethality
@ast
BAG3 deficiency results in fulminant myopathy and early lethality
@en
BAG3 deficiency results in fulminant myopathy and early lethality
@nl
P2093
P2860
P3181
P1476
BAG3 deficiency results in fulminant myopathy and early lethality
@en
P2093
Eva Engvall
G. Diane Shelton
John C. Reed
Masahiro Iwasaki
Sachiko Homma
Shinichi Takayama
P2860
P304
P3181
P356
10.2353/AJPATH.2006.060250
P407
P577
2006-09-01T00:00:00Z